Skip to main content

Table 2 Sera reacting with MUC1 glycoforms when screened against arrays displaying glycoforms shown in Figure 1B

From: Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

  Sera from patients with benign breast disease used to define cut-off Sera from age-matched healthy females used to define cut-off
  P< 0.0001 P= 0.0007
  Breast cancer n (%) Benign disease n (%) Breast cancer n (%) Healthy females n (%)
negative 271 (69) 97 (90) 272 (69) 85 (86)
positive1 124 (31) 11 (10) 123 (31) 14 (14)
strong positive2 97 (24) 8 (7) 80 (20) 7 (7)
  1. 1Sera was defined as positive if it was two standard deviations or higher than the mean fluorescence for at least one feature.
  2. 2 Sera was defined as strong positive if four standard deviations or higher than the mean fluorescence for at least one feature